Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGH | Q92820 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 8/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | NAALAD2 | Q9Y3Q0 | 5/20 | 0.46 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28535426 | 1.00 | GGH (0.48) | GGHFOLH1GAACA2CA1 | |
| SCHEMBL11651630 | 0.89 | KMT2A (0.50) | GGHFOLH1GAACA2CA1 | |
| SCHEMBL11651627 | 0.89 | KMT2A (0.50) | GGHFOLH1GAACA2CA1 | |
| SCHEMBL14089665 | 0.86 | MAPT (0.42) | FOLH1CA2CA1MMP9 | |
| Hydrochloric Acid SCHEMBL4956559 | 0.85 | MAPT (0.41) | FOLH1CA2CA1MMP9 | |
| SCHEMBL60371 | 0.84 | GAA (0.62) | GGHFOLH1GAANAALAD2RIMKLA | |
| SCHEMBL60370 | 0.84 | GAA (0.62) | GGHFOLH1GAANAALAD2RIMKLA | |
| SCHEMBL5497952 | 0.83 | FOLH1 (0.59) | GGHFOLH1GAA | |
| SCHEMBL11835127 | 0.83 | GGH (0.48) | GGHFOLH1GAACA2CA1 | |
| SCHEMBL4829872 | 0.83 | ITGB3 (0.47) | GAACA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7384432-B2 | Secondary para-phenylenediamines having a carboxyl group, dye compositions comprising the same, and dyeing processes using the compositions | L'OREAL S.A. (FR) | 2008-06-10 | — | — | US | claimed |
| US-20060021159-A1 | Secondary para-phenylenediamines having a carboxyl group, dye compositions comprising the same, and dyeing processes using the compositions | L'OREAL S.A. (FR) | 2006-02-02 | — | — | US | claimed |
| EP-1580186-A1 | Secondary p-phenylendiamines containing a carboxylic acid group, dye composition containing them, processes and uses | L'OREAL (FR) | 2005-09-28 | — | — | EP | claimed |
| CN-109180678-A | A kind of L-5- methyl tetrahydrofolate salt crystal form and preparation method thereof | 江苏红豆杉药业有限公司 | 2019-01-11 | — | — | CN | disclosed |
| CN-102516247-A | A-type calcium L-5-methyltetrahydrofolate polymorphism and preparation method thereof | LIANYUNGANG JINKANG PHARMACEUTICAL TECHNOLOGY CO LTD | 2012-06-27 | — | — | CN | disclosed |
| US-7384432-B2 | Secondary para-phenylenediamines having a carboxyl group, dye compositions comprising the same, and dyeing processes using the compositions | L'OREAL S.A. (FR) | 2008-06-10 | — | — | US | disclosed |
| US-20060021159-A1 | Secondary para-phenylenediamines having a carboxyl group, dye compositions comprising the same, and dyeing processes using the compositions | L'OREAL S.A. (FR) | 2006-02-02 | — | — | US | disclosed |
| EP-1580186-A1 | Secondary p-phenylendiamines containing a carboxylic acid group, dye composition containing them, processes and uses | L'OREAL (FR) | 2005-09-28 | — | — | EP | disclosed |
| US-RE29724-E | NYLON, WITH AN ANTHRAQUINONE DYE CONTAINING CYCLIC ANHYDRIDE (FORMING) GROUPS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060021159-A1 | Secondary para-phenylenediamines having a carboxyl group, dye compositions comprising the same, and dyeing processes using the compositions | KRT18, CDC73, JUP | GGH 1938/4885FOLH1 1427/4885GAA 4473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.